Quotables
"That’s an amazing invention, but who would ever want to use one of them?"
President Rutherford B. Hayes ; Said in 1876, after Alexander Graham Bell demonstrated the telephone to him at the White House
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 8158609 | Use of cyclodextrins as an active ingredient for treating dry AMD and solubilizing drusen The present invention is directed to the treatment of disorders involving the accumulation of drusen, such as dry age-related macular degeneration and geographic atrophy via administration of therapeutically effective amounts of at least one monomeric or polymeric c... | 04/17/2012 |
| 7981858 | Methods of using zinc containing compounds to improve ocular health The present invention provides zinc complexes for use in methods of providing zinc to subjects in need of treatment. The invention further provides improved dietary supplement formulations for improving and maintaining ocular nutrition. In particular, the improved d... | 07/19/2011 |
| 7842722 | Composition and methods for inhibiting the progression macular degeneration and promoting healthy vision The present invention provides improved dietary supplements and methods for inhibiting the progression of macular degeneration and promoting healthy vision. The dietary supplements of the invention contain cobeadlets comprising vitamin E and carotenoids in the form ... | 11/30/2010 |
| 7763619 | Compounds with 5-HTactivity useful for treating disorders of the outer retina Compositions and methods for treating disorders of the outer retina with compounds with 5-HT1A agonist activity are disclosed. ... | 07/27/2010 |
| 7718697 | Method for treating glaucoma comprising administering α-lipoic acid The present invention provides compositions and methods for treating glaucoma, ocular hypertension, and age-related macular degeneration. More specifically, the present invention describes the use of agents that down-regulate expression of tanis and/or p21Waf1/... | 05/18/2010 |
| 7662389 | Use of serum amyloid A gene in diagnosis and treatment of glaucoma and identification of anti-glaucoma agents The present invention provides compositions and methods for treating glaucoma, methods for diagnosing glaucoma, and methods for identifying agents which may be useful in the treatment of glaucoma. More specifically, the present invention describes the use of agents ... | 02/16/2010 |
| 7598288 | Inhibitors of glycogen synthase kinase-3 (GSK-3) for treating glaucoma The use of inhibitors of GSK-3 useful for treating glaucoma is disclosed. ... | 10/06/2009 |
| 7488723 | Use of non-feminizing estrogens as treatment for retinal vascular diseases The invention provides pharmaceutical compositions containing non-feminizing estrogen and methods of using these compositions to prevent or ameliorate retinal vascular diseases. ... | 02/10/2009 |
| 7384926 | Use of non-feminizing estrogens as retinoprotective agents for the treatment of glaucoma The invention provides pharmaceutical compositions containing non-feminizing estrogen and methods of using these compositions to prevent or ameliorate retinal and optic nerve damage associated with glaucoma. ... | 06/10/2008 |
| 7357931 | Use of serum amyloid a gene in diagnosis and treatment of glaucoma and identification of anti-glaucoma agents The present invention provides compositions and methods for treating glaucoma, methods for diagnosing glaucoma, and methods for identifying agents which may be useful in the treatment of glaucoma. More specifically, the present invention describes the use of agents ... | 04/15/2008 |
| 7267830 | Composition and methods for inhibiting the progression macular degeneration and promoting healthy vision The present invention provides improved dietary supplements and methods for inhibiting the progression of macular degeneration and promoting healthy vision. The dietary supplements of the invention contain cobeadlets comprising vitamin E and carotenoids in the form ... | 09/11/2007 |
| 7220546 | Methods for diagnosing glaucoma and discovering anti-glaucoma drugs Methods for diagnosing glaucoma and for screening therapeutic agents for their usefulness in treating glaucoma are disclosed. ... | 05/22/2007 |
| 7081482 | Use of β-adrenoceptor antagonists for the manufacture of a medicament for the treatment of disorders of the outer retina The invention is directed to the use of β-adrenoceptor antagonists for the manufacture of a medicament for the treatment of disorders of the outer retina. ... | 07/25/2006 |
| 7012090 | Pyranoindoles for treating glaucoma Substituted pyranoindoles useful for lowering and controlling IOP and glaucoma are disclosed. ... | 03/14/2006 |
| 7005446 | Use of AP-1 activators to treat glaucoma and ocular hypertension Compositions comprising AP-1 activators and methods of use for treating glaucoma and ocular hypertension are disclosed. ... | 02/28/2006 |
| 6956036 | 6-hydroxy-indazole derivatives for treating glaucoma Substituted 1-(α-alkyl-ethylamino)-1H-indazol-6-ols useful for lowering and controlling IOP and treating glaucoma are disclosed ... | 10/18/2005 |
| 6906077 | Use of neurotrophic factor stimulators for the treatment of ophthalmic neurodegenerative diseases Compositions and methods for the treatment of retina and optic nerve head neuropathy are disclosed. The compositions and methods are particularly directed to the use of neurotrophic factor stimulators, such as AIT-082 (neotrofin), in the treatment of glaucomatous ne... | 06/14/2005 |
| 6716447 | Stable carotene xanthophyll beadlet compositions and methods of use Beadlets comprising xanthophylls and carotenes and/or retinoids, dietary supplements comprising these beadlets and methods of use are disclosed. ... | 04/06/2004 |
| 6696476 | Pyranoindazoles and their use for the treatment of glaucoma Pyranoindazoles are disclosed. Also disclosed are methods for the lowering and controlling of normal or elevated intraocular pressure as well as a method for the treatment of glaucoma using compositions containing one or more of the compounds of the prese... | 02/24/2004 |
| 6664286 | Serotonergic 5ht2 agonists for treating glaucoma Compounds with 5HT2 receptor agonist activity useful for treating glaucoma, including lowering intraocular pressure. Compositions and methods for their use are also disclosed.... | 12/16/2003 |
| 6660870 | 2-acylaminobenzimidazole derivatives for treating glaucoma 2-Acylaminobenzimidazole deviates useful for treating glaucoma are disclosed.... | 12/09/2003 |
| 6649602 | Use of an H1 antagonist and a safe steroid to treat eye conditions Composition and method of treating VKC, GPC, and AKC with H1 antagonists and ocularly safe steroids are disclosed.... | 11/18/2003 |
| 6638976 | Method of treating neurodegenerative disorders of the retina and optic nerve head The use of 3-benzolphenylacetic acids and derivatives, including nepafenac, to treat neurodegenerative retinal disorders is disclosed.... | 10/28/2003 |
| 6582721 | Stable carotene-xanthophyll beadlet compositions and methods of use Beadlets comprising xanthophylls and carotenes and/or retinoids, dietary supplements comprising these beadlets and methods of use are disclosed.... | 06/24/2003 |
